Hawkins, Inc. (NASDAQ:HWKN) Director Purchases $172,940.00 in Stock

Hawkins, Inc. (NASDAQ:HWKN) Director James A. Faulconbridge bought 2,000 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The stock was bought at an average cost of $86.47 per share, for a total transaction of $172,940.00. Following the completion of the transaction, the director now directly owns 44,017 shares of the company’s stock, valued at approximately $3,806,149.99. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Hawkins Price Performance

HWKN opened at $86.49 on Friday. The company’s 50 day simple moving average is $81.27 and its 200 day simple moving average is $73.00. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.24 and a current ratio of 1.96. Hawkins, Inc. has a 1 year low of $45.37 and a 1 year high of $90.71. The stock has a market capitalization of $1.81 billion, a PE ratio of 24.09, a P/E/G ratio of 3.95 and a beta of 0.78.

Hawkins (NASDAQ:HWKN) last announced its quarterly earnings results on Wednesday, May 15th. The specialty chemicals company reported $0.66 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.02). The business had revenue of $223.02 million for the quarter, compared to analyst estimates of $217.49 million. Hawkins had a net margin of 8.20% and a return on equity of 19.41%. As a group, sell-side analysts expect that Hawkins, Inc. will post 3.67 EPS for the current year.

Hawkins Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, June 14th. Shareholders of record on Friday, May 31st were given a dividend of $0.16 per share. The ex-dividend date was Friday, May 31st. This represents a $0.64 dividend on an annualized basis and a yield of 0.74%. Hawkins’s dividend payout ratio (DPR) is 17.83%.

Wall Street Analyst Weigh In

Separately, BWS Financial raised their target price on shares of Hawkins from $74.00 to $96.00 and gave the stock a “buy” rating in a research report on Friday, May 17th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Westwood Holdings Group Inc. acquired a new position in Hawkins during the first quarter valued at approximately $31,504,000. DekaBank Deutsche Girozentrale lifted its position in Hawkins by 28.1% during the first quarter. DekaBank Deutsche Girozentrale now owns 11,934 shares of the specialty chemicals company’s stock valued at $915,000 after buying an additional 2,618 shares in the last quarter. Janus Henderson Group PLC lifted its position in Hawkins by 21.6% during the first quarter. Janus Henderson Group PLC now owns 43,243 shares of the specialty chemicals company’s stock valued at $3,320,000 after buying an additional 7,683 shares in the last quarter. Public Employees Retirement System of Ohio lifted its position in Hawkins by 7,343.9% during the first quarter. Public Employees Retirement System of Ohio now owns 22,555 shares of the specialty chemicals company’s stock valued at $1,732,000 after buying an additional 22,252 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its position in Hawkins by 1.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 52,985 shares of the specialty chemicals company’s stock valued at $4,070,000 after buying an additional 693 shares in the last quarter. 69.71% of the stock is owned by institutional investors and hedge funds.

About Hawkins

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.